These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9867134)

  • 1. Fasting and nonfasting iodine-123-idophenylpentadecanoic acid myocardial SPECT imaging in coronary artery disease.
    Heller GV; Iskandrian AE; Orlandi C; Ahlberg AW; Heo J; Mann A; White MP; Gagnon A; Taillefer R
    J Nucl Med; 1998 Dec; 39(12):2019-22. PubMed ID: 9867134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-IPPA SPECT for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Multicenter IPPA Viability Trial Investigators. 123I-iodophenylpentadecanoic acid.
    Verani MS; Taillefer R; Iskandrian AE; Mahmarian JJ; He ZX; Orlandi C
    J Nucl Med; 2000 Aug; 41(8):1299-307. PubMed ID: 10945518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of myocardial viability using 123I-labeled iodophenylpentadecanoic acid at sustained low flow or after acute infarction and reperfusion.
    Yang JY; Ruiz M; Calnon DA; Watson DD; Beller GA; Glover DK
    J Nucl Med; 1999 May; 40(5):821-8. PubMed ID: 10319757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-123 phenylpentadecanoic acid and single photon emission computed tomography in identifying left ventricular regional metabolic abnormalities in patients with coronary heart disease: comparison with thallium-201 myocardial tomography.
    Hansen CL; Corbett JR; Pippin JJ; Jansen DE; Kulkarni PV; Ugolini V; Henderson E; Akers M; Buja LM; Parkey RW
    J Am Coll Cardiol; 1988 Jul; 12(1):78-87. PubMed ID: 3259960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of myocardial viability by dynamic tomographic iodine 123 iodophenylpentadecanoic acid imaging: comparison with rest-redistribution thallium 201 imaging.
    Iskandrian AS; Powers J; Cave V; Wasserleben V; Cassell D; Heo J
    J Nucl Cardiol; 1995; 2(2 Pt 1):101-9. PubMed ID: 9420774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease.
    Fujiwara S; Takeishi Y; Atsumi H; Takahashi K; Tomoike H
    J Nucl Med; 1997 Feb; 38(2):175-80. PubMed ID: 9025730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary report of an ongoing phase I/II dose range, safety and efficacy study of iodine-123-phenylpentadecanoic acid for the identification of viable myocardium.
    Hansen CL
    J Nucl Med; 1994 Apr; 35(4 Suppl):38S-42S. PubMed ID: 8151411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial viability assessment with dynamic low-dose iodine-123-iodophenylpentadecanoic acid metabolic imaging: comparison with myocardial biopsy and reinjection SPECT thallium after myocardial infarction.
    Murray GL; Schad NC; Magill HL; Vander Zwaag R
    J Nucl Med; 1994 Apr; 35(4 Suppl):43S-48S. PubMed ID: 8151413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of improvement in left ventricular function with iodine-123-IPPA after coronary revascularization.
    Hansen CL; Heo J; Oliner C; Van Decker W; Iskandrian AS
    J Nucl Med; 1995 Nov; 36(11):1987-93. PubMed ID: 7472586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of myocardial p-(123)I-iodophenylpentadecanoic acid retention with (18)F-FDG accumulation during experimental low-flow ischemia.
    Shi CQ; Young LH; Daher E; DiBella EV; Liu YH; Heller EN; Zoghbi S; Wackers FJ; Soufer R; Sinusas AJ
    J Nucl Med; 2002 Mar; 43(3):421-31. PubMed ID: 11884504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viability after myocardial infarction: can it be assessed within five minutes by low-dose dynamic iodine-123-iodophenylpentadecanoic acid imaging with a multicrystal gamma camera?
    Murray GL; Schad N; Bush AJ
    Angiology; 1997 Apr; 48(4):309-19. PubMed ID: 9112879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT.
    Sloof GW; Visser FC; Bax JJ; van Lingen A; Eersels J; Knapp FF; Teule GJ
    J Nucl Med; 1998 Feb; 39(2):255-60. PubMed ID: 9476931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scintigraphy with 123I-labelled fatty acids in coronary heart disease].
    Kropp J; Köhler U; Likungu J; Reichmann K; Lüderitz B; Biersack HJ
    Dtsch Med Wochenschr; 1991 Jun; 116(23):881-6. PubMed ID: 2040206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined thallium-201 and dynamic iodine-123 iodophenylpentadecanoic acid single-photon emission computed tomography in patients after acute myocardial infarction with effective reperfusion.
    Richter WS; Beckmann S; Cordes M; Schuppenhauer T; Schartl M; Munz DL
    Clin Cardiol; 2000 Dec; 23(12):902-8. PubMed ID: 11129676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of 123I-phenylpentadecanoic acid (IPPA) metabolic and thallium 201 perfusion imaging in stable coronary artery disease.
    Walamies M; Turjanmaa V; Koskinen M; Uusitalo A
    Eur Heart J; 1993 Aug; 14(8):1079-87. PubMed ID: 8404938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease].
    Tillmanns H; Zimmermann R; Kapp M; Rauch B; Neumann FJ; Schlumpp K; Bubeck B; Georgi P; Kübler W
    Z Kardiol; 1989; 78 Suppl 5():77-82. PubMed ID: 2698567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iodophenylpentadecanoic acid-myocardial blood flow relationship during maximal exercise with coronary occlusion.
    Caldwell JH; Martin GV; Link JM; Krohn KA; Bassingthwaighte JB
    J Nucl Med; 1990 Jan; 31(1):99-105. PubMed ID: 2295946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic cardiac imaging in severe coronary disease: assessment of viability with iodine-123-iodophenylpentadecanoic acid and multicrystal gamma camera, and correlation with biopsy.
    Murray G; Schad N; Ladd W; Allie D; vander Zwagg R; Avet P; Rockett J
    J Nucl Med; 1992 Jul; 33(7):1269-77. PubMed ID: 1613564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia.
    Kennedy PL; Corbett JR; Kulkarni PV; Wolfe CL; Jansen DE; Hansen CL; Buja LM; Parkey RW; Willerson JT
    Circulation; 1986 Nov; 74(5):1007-15. PubMed ID: 3769161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single photon emission tomography imaging of myocardial oxidative metabolism with 15-(p-[123I]iodophenyl) pentadecanoic acid in patients with coronary artery disease and aorto-coronary bypass graft surgery.
    Kropp J; Likungu J; Kirchhoff PG; Knapp FF; Reichmann K; Reske SN; Biersack HJ
    Eur J Nucl Med; 1991; 18(7):467-74. PubMed ID: 1915473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.